Covered recipient · General Payments record
KEITH MICHAEL PRITCHYK
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2023
$869.68
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $170.95 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $47.07 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.46 | 2 |
| Genentech USA, Inc. | $23.17 | 1 |
| GlaxoSmithKline, LLC. | $22.67 | 1 |
| Acerta Pharma LLC | $21.13 | 1 |
| Merck Sharp & Dohme Corporation | $15.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $21.13 | 03/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011753333 | CMS |
| Genentech USA, Inc. | $23.17 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040425263 | CMS |
| GENZYME CORPORATION | $18.48 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049923267 | CMS |
| GENZYME CORPORATION | $28.59 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049923319 | CMS |
| GlaxoSmithKline, LLC. | $22.67 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001601497 | CMS |
| Merck Sharp & Dohme LLC | $15.45 | 10/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048555847 | CMS |
| Novartis Pharmaceuticals Corporation | $19.32 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992887361 | CMS |
| Novartis Pharmaceuticals Corporation | $22.14 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992887387 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.